This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada has been postponed to July 6 - 9, 2021 and will now be delivered Virtually.

Speakers

Justin_Bailey_HCV_2020_125px.png

Justin Bailey

Associate Professor of Medicine
Johns Hopkins University School of Medicine
USA

Dr. Bailey is an Associate Professor of Medicine and an Infectious Diseases physician at the Johns Hopkins University School of Medicine in Baltimore, Maryland. He earned his M.D. and Ph.D. degrees from Johns Hopkins and completed medical residency training at Massachusetts General Hospital in Boston, Massachusetts. His clinical focus is on treatment of viral hepatitis and HIV infection. His laboratory focuses on virus-host interactions, with a particular focus on broadly neutralizing antibodies against hepatitis C virus (HCV).

Recent publications:
Kinchen VJ, Massaccesi G, Flyak AI, Mankowski MC, Colbert MD, Osburn WO, Ray SC, Cox AL, Crowe JE Jr, Bailey JR. Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance. J Clin Invest. 2019 Aug 13;130.

Flyak AI, Ruiz S, Colbert MD, Luong T, Crowe JE Jr, Bjorkman PJ*, Bailey JR*. HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design. Cell Host Microbe. 2018 Nov 14;24(5):703-716.e3. *co-corresponding authors.

Kinchen VJ, Zahid MN, Flyak AI, Soliman MG, Learn GH, Wang S, Davidson E, Doranz BJ, Ray SC, Cox AL, Crowe JE Jr, Bjorkman PJ, Shaw GM, Bailey JR. Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. Cell Host Microbe. 2018 Nov 14;24(5):717-730.e5.

Return to Speakers